From Lab to Lasting: Building Life Science and Biotech Companies That Endure

An evening at White City Place for biotech, medtech, diagnostics and digital-health founders on the unglamorous machinery that decides whether a spinout scales: IP strategy and when to file, the UK grant and early-capital stack (Innovate UK, SEIS/EIS, VC) and how to sequence it, what investors actually diligence in a science-led company, and the financial foundations that keep a biotech investor-ready. Hosted by Lightbringer, Novabook and WilbeLabs, with honest stories from founders who have made the lab-to-company jump. Panel and Q&A from 18:30, food at 19:30. Free, ticket types for founders, investors and ecosystem — approval required.